Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
US Army
US Department of Justice
Queensland Health
Julphar
Accenture
Baxter
Healthtrust
Chubb

Generated: May 21, 2018

DrugPatentWatch Database Preview

ISOSULFAN BLUE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Drug patent expirations by year for ISOSULFAN BLUE
Synonyms for ISOSULFAN BLUE
(4-(alpha-(p-(Diethylamino)phenyl)-2,5-disulfobenzylidene)-2,5-cyclohexadien-1-ylidene)diethylammonium hydroxide, inner salt, sodium salt
39N9K8S2A4
68238-36-8
AC1L18GW
AC1Q1VDY
AKOS015904521
AN-38145
CAS-68238-36-8
CHEMBL1200859
D04634
D0P2YD
DB09136
Disulphin Blau
DSSTox_CID_31594
DSSTox_GSID_57805
DSSTox_RID_97478
DTXSID8057805
Ethanaminium, N-(4-((4-(diethylamino)phenyl)(2,5-disulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-ethyl-, hydroxide, inner salt, sodium salt
I14-17361
Iso-sulfan blue
Isosulfan blue (USAN)
Isosulfan blue [USAN]
LS-186487
LYMPHAZURIN
Lymphazurin (TN)
MFCD00867653
natrium-2-{[4-(diethylamino)phenyl][4-(diethyliminio)cyclohexa-2,5-dien-1-yliden]methyl}benzol-1,4-disulfonat
NCGC00253597-01
OR076619
P 1888
P 4125
P-4125
Patent blau V
Patentblau V
SCHEMBL3324345
Sodium 2-((4-(diethylamino)phenyl)(4-(diethyliminio)cyclohexa-2,5-dien-1-ylidene)methyl)benzene-1,4-disulfonate
sodium 2-[[4-(diethylamino)phenyl]-(4-diethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]benzene-1,4-disulfonate
sodium 2-[[4-(diethylamino)phenyl]-(4-diethyliminiocyclohexa-2,5-dien-1-ylidene)methyl]benzene-1,4-disulfonate
SODIUM BIS[4-(DIETHYLAMINO)PHENYL](2,5-DISULFONATOPHENYL)METHYLIUM
Sulfanblau
Sulphan Blue
Sulphan blue 2,5-disulfophenyl isomer
Tox21_113733
UNII-39N9K8S2A4

US Patents and Regulatory Information for ISOSULFAN BLUE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd ISOSULFAN BLUE isosulfan blue INJECTABLE;INJECTION 206831-001 Feb 2, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Institutional ISOSULFAN BLUE isosulfan blue INJECTABLE;INJECTION 090874-001 Jul 20, 2010 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Chinese Patent Office
McKinsey
UBS
Federal Trade Commission
McKesson
Mallinckrodt
Accenture
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.